Swedish Orphan Biovitrum AB (BIOVF) Ratios
Swedish Orphan Biovitrum AB Ratios
BIOVF's free cash flow for Q3 2026 was $1.86B. For the 2026 fiscal year, BIOVF's free cash flow was decreased by $-5.00M and operating cash flow was $1.87B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.90 | 1.04 | 0.66 | 0.75 | 1.00 |
| Quick Ratio | 0.59 | 0.71 | 0.46 | 0.53 | 0.61 |
| Cash Ratio | 0.06 | 0.09 | 0.05 | 0.09 | 0.12 |
| Solvency Ratio | 0.36 | 0.22 | 0.14 | 0.19 | 0.18 |
| Operating Cash Flow Ratio | 0.53 | 0.59 | 0.23 | 0.31 | 0.62 |
| Short-Term Operating Cash Flow Coverage | 1.44 | 1.88 | 0.51 | 0.80 | 3.09 |
| Net Current Asset Value | $ -15.18B | $ -21.99B | $ -27.49B | $ -14.76B | $ -16.68B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.17 | 0.22 | 0.28 | 0.17 | 0.22 |
| Debt-to-Equity Ratio | 0.30 | 0.42 | 0.60 | 0.34 | 0.47 |
| Debt-to-Capital Ratio | 0.23 | 0.29 | 0.38 | 0.26 | 0.32 |
| Long-Term Debt-to-Capital Ratio | 0.12 | 0.24 | 0.25 | 0.10 | 0.27 |
| Financial Leverage Ratio | 1.79 | 1.87 | 2.19 | 1.98 | 2.10 |
| Debt Service Coverage Ratio | 1.68 | 1.70 | 0.67 | 0.86 | 2.33 |
| Interest Coverage Ratio | 9.68 | 4.54 | 3.66 | 8.31 | 8.91 |
| Debt to Market Cap | 0.10 | 0.15 | 0.23 | 0.13 | 0.18 |
| Interest Debt Per Share | 35.80 | 52.60 | 66.93 | 30.89 | 36.66 |
| Net Debt to EBITDA | 0.95 | 1.68 | 2.71 | 1.28 | 1.73 |
| Profitability Margins | |||||
| Gross Profit Margin | 43.63% | 77.77% | 77.42% | 74.58% | 77.56% |
| EBIT Margin | 3.07% | 21.61% | 18.37% | 20.12% | 23.92% |
| EBITDA Margin | 38.82% | 35.75% | 32.70% | 32.21% | 36.79% |
| Operating Profit Margin | 28.50% | 21.61% | 18.38% | 20.29% | 24.04% |
| Pretax Profit Margin | 0.12% | 16.93% | 13.35% | 17.67% | 21.22% |
| Net Profit Margin | 1.69% | 14.93% | 10.89% | 14.04% | 17.25% |
| Continuous Operations Profit Margin | 1.69% | 14.90% | 10.88% | 14.04% | 17.25% |
| Net Income Per EBT | 1405.88% | 88.16% | 81.55% | 79.43% | 81.31% |
| EBT Per EBIT | 0.42% | 78.35% | 72.65% | 87.10% | 88.27% |
| Return on Assets (ROA) | 0.71% | 5.15% | 3.25% | 5.03% | 5.51% |
| Return on Equity (ROE) | 1.27% | 9.64% | 7.11% | 9.95% | 11.55% |
| Return on Capital Employed (ROCE) | 15.67% | 8.95% | 7.40% | 10.13% | 9.36% |
| Return on Invested Capital (ROIC) | 14.02% | 7.40% | 5.19% | 6.95% | 7.26% |
| Return on Tangible Assets | 2.60% | 23.58% | 17.32% | 21.13% | 26.17% |
| Earnings Yield | 0.42% | 3.58% | 2.80% | 3.95% | 4.69% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.38 | 3.53 | 3.13 | 3.06 | 3.78 |
| Payables Turnover | 12.89 | 6.13 | 4.88 | 3.81 | 6.24 |
| Inventory Turnover | 3.10 | 1.39 | 1.29 | 1.43 | 1.02 |
| Fixed Asset Turnover | 17.31 | 16.43 | 88.14 | 68.58 | 31.50 |
| Asset Turnover | 0.42 | 0.34 | 0.30 | 0.36 | 0.32 |
| Working Capital Turnover Ratio | -57.69 | -8.88 | -4.39 | -10.35 | -13.75 |
| Cash Conversion Cycle | 197.30 | 306.36 | 324.77 | 278.25 | 396.74 |
| Days of Sales Outstanding | 108.06 | 103.51 | 116.51 | 119.29 | 96.49 |
| Days of Inventory Outstanding | 117.56 | 262.41 | 283.09 | 254.64 | 358.71 |
| Days of Payables Outstanding | 28.32 | 59.56 | 74.83 | 95.68 | 58.46 |
| Operating Cycle | 225.62 | 365.92 | 399.60 | 373.93 | 455.20 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 24.87 | 21.62 | 13.85 | 15.07 | 17.71 |
| Free Cash Flow Per Share | 24.76 | 12.83 | -1.47 | 10.30 | 16.51 |
| Dividend Paid and CapEx Coverage Ratio | 214.10 | 2.46 | 0.90 | 3.16 | 14.78 |
| Capital Expenditure Coverage Ratio | 214.10 | 2.46 | 0.90 | 3.16 | 14.78 |
| Operating Cash Flow Coverage Ratio | 0.75 | 0.44 | 0.22 | 0.51 | 0.50 |
| Operating Cash Flow to Sales Ratio | 0.30 | 0.28 | 0.20 | 0.25 | 0.35 |
| Free Cash Flow Yield | 7.44% | 4.04% | -0.55% | 4.78% | 8.92% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 239.42 | 27.92 | 35.76 | 25.30 | 21.34 |
| Price-to-Sales (P/S) Ratio | 4.06 | 4.17 | 3.89 | 3.55 | 3.68 |
| Price-to-Book (P/B) Ratio | 3.04 | 2.69 | 2.54 | 2.52 | 2.46 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 13.44 | 24.75 | -182.14 | 20.94 | 11.21 |
| Price-to-Operating Cash Flow Ratio | 13.38 | 14.68 | 19.27 | 14.31 | 10.45 |
| Price-to-Earnings Growth (PEG) Ratio | -2.73 | 0.53 | -2.90 | -14.63 | -1.21 |
| Enterprise Value Multiple | 11.41 | 13.33 | 14.62 | 12.31 | 11.73 |
| Enterprise Value | 125.04B | 124.06B | 105.73B | 74.49B | 67.04B |
| EV to EBITDA | 11.41 | 13.33 | 14.62 | 12.31 | 11.73 |
| EV to Sales | 4.43 | 4.77 | 4.78 | 3.96 | 4.32 |
| EV to Free Cash Flow | 14.67 | 28.30 | -223.53 | 23.37 | 13.14 |
| EV to Operating Cash Flow | 14.60 | 16.79 | 23.65 | 15.97 | 12.26 |
| Tangible Book Value Per Share | -32.99 | -54.65 | -81.36 | -43.58 | -49.27 |
| Shareholders’ Equity Per Share | 109.55 | 117.89 | 104.96 | 85.71 | 75.12 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -13.00 | 0.12 | 0.18 | 0.21 | 0.19 |
| Revenue Per Share | 82.02 | 76.16 | 68.56 | 60.72 | 50.27 |
| Net Income Per Share | 1.39 | 11.37 | 7.47 | 8.52 | 8.67 |
| Tax Burden | 14.06 | 0.88 | 0.82 | 0.79 | 0.81 |
| Interest Burden | 0.04 | 0.78 | 0.73 | 0.88 | 0.89 |
| Research & Development to Revenue | 0.12 | 0.14 | 0.13 | 0.13 | 0.13 |
| SG&A to Revenue | 0.39 | 0.29 | 0.46 | 0.42 | 0.41 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Income Quality | 17.92 | 1.68 | 1.86 | 1.40 | 1.66 |
Currency in SEK